ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor

November 14, 1997

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990

NCAB Committee Still Debating How To Encourage Surgical Oncology

April 26, 1985

Study: End-of-Life Chemotherapy Leads to More Deaths in Hospital

March 28, 2014

RFA/PA/Drug Group Announcement Limited

May 6, 1988

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992